RxDoctor Payments Data

Oren Goltzer, MD

Orthopaedic Surgery · Atlanta, GANPI 1316213788

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 64.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $863 and has fallen 80.1% since, to $171 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in GA, where the typical reported total is $3,375.

$1,890in general payments, 2019–2025

Across 29 payments — averaging $65.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Stryker$384
  • Zimmer Biomet$136
  • Conformis, Inc.$89
  • Johnson & Johnson$42
  • X-spine Systems, Inc.$13

What the payments were for

  • Travel & lodging$965%
  • Food & beverage$1,79495%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew15$1,225
Stryker9$384
Zimmer Biomet1$136
Conformis, Inc.1$89
Johnson & Johnson(2 entities)2$42
X-spine Systems, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,890 in reported general payments places this provider in the 35th percentile of 654 orthopaedic surgery providers in Georgia.

See all orthopaedic surgery providers in Georgia →

Medicare billing

Part B allowed, 2024
$310,699
Medicare patients
403
Services billed
3,304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib297$9,715
EliquisApixaban24$5,052
Ondansetron Hcl265$2,953
Diclofenac Sodium102$1,851
Cefadroxil224$1,566
Oxycodone Hcl154$1,140
Doxycycline Hyclate14$550
Hydromorphone Hcl30$254
Gabapentin40$246
Meloxicam115$200
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim41$154
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$145
Methylprednisolone28$131
Tramadol Hcl29$85
Amoxicillin84$74

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →